Corrigendum to “Safety, Tolerability, Pharmacokinetics, and Efficacy of Terlipressin Delivered by Continuous Intravenous Infusion in Patients with Cirrhosis and Refractory Ascites”

Bajaj, Jasmohan S.; Fischer, James H.; Yeramian, Patrick; Gavis, Edith A.; Fagan, Andrew; Angeli, Paolo; Garcia-Tsao, Guadalupe; Adams, Jonathan M.; Markham, Penelope

doi:https://doi.org/10.1155/2023/9815951

GastroHep

On this page

References Copyright Related Articles

Research Article Corrigendum

Corrigendum | Open Access

Volume 2023 | Article ID 9815951 | https://doi.org/10.1155/2023/9815951

Corrigendum to “Safety, Tolerability, Pharmacokinetics, and Efficacy of Terlipressin Delivered by Continuous Intravenous Infusion in Patients with Cirrhosis and Refractory Ascites”

Jasmohan S. Bajaj,¹James H. Fischer,²Patrick Yeramian,³Edith A. Gavis,⁴Andrew Fagan,⁴Paolo Angeli,⁵Guadalupe Garcia-Tsao,⁶Jonathan M. Adams,³and Penelope Markham³

Received03 Nov 2022

Accepted03 Nov 2022

Published06 Feb 2023

In the article titled “Safety, Tolerability, Pharmacokinetics, and Efficacy of Terlipressin Delivered by Continuous Intravenous Infusion in Patients with Cirrhosis and Refractory Ascites” [1], there was an error in the Conflicts of Interest section, where Jasmohan S. Bajaj was incorrectly listed as an employee of BioVie, Inc. Additionally, some additional information was omitted in error. The corrected section appears in the following:

Conflicts of Interest

JF and PY are consultants who received compensation from BioVie. EG and AF received none. PA is a clinical advisor who received honorarium from BioVie and from Grifols. GG-T is a clinical advisor who received honorarium from BioVie. JSB received grant support to his institution from BioVie. JA and PM are BioVie employees.

References

J. S. Bajaj, J. H. Fischer, P. Yeramian et al., “Safety, Tolerability, Pharmacokinetics, and Efficacy of Terlipressin Delivered by Continuous Intravenous Infusion in Patients with Cirrhosis and Refractory Ascites,” GastroHep, vol. 2022, article 5065478, 8 pages, 2022.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2023 Jasmohan S. Bajaj et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

257

Downloads

235

Citations